Crowley and Canzater identify five critical actions that should be priorities for monitoring HCV: 1) expand and standardize reporting to the CDC, 2) utilize electronic medical records to collect data on HCV cases and the cure cascade, 3)
fund epidemiologic research using clinical data sets, 4) integrate improved monitoring of HCV with responses to the opioid epidemic, and 5) establish and monitor HCV elimination plans across major US health systems.
From an
epidemiologic perspective, preeclampsia is growing at a rate more rapid than diabetes, heart disease, Alzheimer's disease, obesity, and chronic kidney disease — diseases for which substantial
research and treatment
funding have been allocated,» explained senior investigator Anupam B. Jena, MD, PhD, Ruth L. Newhouse Associate Professor, Department of Health Care Policy, Harvard Medical School, and Massachusetts General Hospital, Boston, MA.